297 related articles for article (PubMed ID: 12090325)
21. Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.
Oshima S; Kawamura O
Clin Exp Nephrol; 2008 Aug; 12(4):264-269. PubMed ID: 18324350
[TBL] [Abstract][Full Text] [Related]
22. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
23. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
24. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
[TBL] [Abstract][Full Text] [Related]
25. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
26. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
[TBL] [Abstract][Full Text] [Related]
27. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
28. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K; Nakanishi K; Ito S; Saito M; Sako M; Ishikura K; Hataya H; Honda M; Iijima K; Yoshikawa N;
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
Tan M; Li W; Zou G; Zhang C; Fang J
Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
[TBL] [Abstract][Full Text] [Related]
31. Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatment.
Kondo N; Moriyama T; Tachikawa M; Tomita E; Hattori A; Yamamura Y; Nonaka M
Auris Nasus Larynx; 2019 Oct; 46(5):764-771. PubMed ID: 30665673
[TBL] [Abstract][Full Text] [Related]
32. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
Hoshino Y; Kaga T; Abe Y; Endo M; Wakai S; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
[TBL] [Abstract][Full Text] [Related]
33. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive therapy for active IgA nephropathy is effective and safe, even in "elderly" patients.
Fukuda M; Hotta O; Mizuno M; Ogiyama Y; Ohte N
Clin Exp Nephrol; 2016 Dec; 20(6):832-834. PubMed ID: 27443481
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Stangou M; Papagianni A; Bantis C; Moisiadis D; Kasimatis S; Spartalis M; Pantzaki A; Efstratiadis G; Memmos D
Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517
[TBL] [Abstract][Full Text] [Related]
38. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
39. Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy.
Kuriki M; Asahi K; Asano K; Sakurai K; Eiro M; Suzuki H; Watanabe K; Katoh T; Watanabe T
Nephrol Dial Transplant; 2003 Jul; 18(7):1311-5. PubMed ID: 12808167
[TBL] [Abstract][Full Text] [Related]
40. Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Kawasaki Y; Suyama K; Miyazaki K; Kanno S; Ono A; Suzuki Y; Sato M; Hashimoto K; Hosoya M
Nephrology (Carlton); 2014 Jul; 19(7):384-91. PubMed ID: 24646214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
